Clinical Trials Browser

OTHER × HER2-negative Breast Cancer × Cisplatin × Clear all

NCT04848454 2022-10-18

Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy

Phase 2 Unknown

HER2-negative Breast Cancer